DSpace Repository

XPC DEFICIENCY INCREASES RISK OF HEMATOLOGIC MALIGNANCIES THROUGH MUTATOR PHENOTYPE AND CHARACTERISTIC MUTATIONAL SIGNATURE

Show simple item record

dc.contributor.author Yurchenko, Andrey A.
dc.contributor.author Padioleau, Ismael
dc.contributor.author Matkarimov, Bakhyt T.
dc.contributor.author Soulier, Jean
dc.contributor.author Sarasin, Alain
dc.contributor.author Nikolaev, Sergey
dc.date.accessioned 2021-02-02T04:49:03Z
dc.date.available 2021-02-02T04:49:03Z
dc.date.issued 2020-11-17
dc.identifier.citation Yurchenko, A. A., Padioleau, I., Matkarimov, B. T., Soulier, J., Sarasin, A., & Nikolaev, S. (2020). XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature. Nature Communications, 11(1). https://doi.org/10.1038/s41467-020-19633-9 en_US
dc.identifier.issn 2041-1723
dc.identifier.uri https://doi.org/10.1038/s41467-020-19633-9
dc.identifier.uri https://www.nature.com/articles/s41467-020-19633-9
dc.identifier.uri http://nur.nu.edu.kz/handle/123456789/5269
dc.description.abstract Recent studies demonstrated a dramatically increased risk of leukemia in patients with a rare genetic disorder, Xeroderma Pigmentosum group C (XP-C), characterized by constitutive deficiency of global genome nucleotide excision repair (GG-NER). The genetic mechanisms of non-skin cancers in XP-C patients remain unexplored. In this study, we analyze a unique collection of internal XP-C tumor genomes including 6 leukemias and 2 sarcomas. We observe a specific mutational pattern and an average of 25-fold increase of mutation rates in XP-C versus sporadic leukemia which we presume leads to its elevated incidence and early appearance. We describe a strong mutational asymmetry with respect to transcription and the direction of replication in XP-C tumors suggesting association of mutagenesis with bulky purine DNA lesions of probably endogenous origin. These findings suggest existence of a balance between formation and repair of bulky DNA lesions by GG-NER in human body cells which is disrupted in XP-C patients. en_US
dc.language.iso en en_US
dc.publisher Nature Research en_US
dc.relation.ispartofseries Nature Communications;11
dc.rights Attribution-NonCommercial-ShareAlike 3.0 United States *
dc.rights.uri http://creativecommons.org/licenses/by-nc-sa/3.0/us/ *
dc.subject Xeroderma Pigmentosum group C en_US
dc.subject XPC en_US
dc.subject hematologic malignancies en_US
dc.subject mutator phenotype en_US
dc.subject mutational signature en_US
dc.subject Research Subject Categories::NATURAL SCIENCES en_US
dc.title XPC DEFICIENCY INCREASES RISK OF HEMATOLOGIC MALIGNANCIES THROUGH MUTATOR PHENOTYPE AND CHARACTERISTIC MUTATIONAL SIGNATURE en_US
dc.type Article en_US
workflow.import.source science


Files in this item

The following license files are associated with this item:

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 United States Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 3.0 United States

Video Guide

Submission guideSubmission guide

Submit your materials for publication to

NU Repository Drive

Browse

My Account

Statistics